E. Bessa

A Retrospective Analysis of the Outcome of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Refractory to a Platinum-based Chemotherapy

Xavier León, Ricardo Hitt, Manuel Constenla et al. · Clinical Oncology · 2005 · 178 citations

Medicine, Cancer Recurrence, Cancer Management +11

Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN): Results of a phase II study

José Trigo, Ricardo Hitt, P. Koralewski et al. · Journal of Clinical Oncology · 2004 · 108 citations

Pathology, Phase Ii Study, Cetuximab Monotherapy +16

Thiopurine methyltransferase activity in a French population: h.p.l.c. assay conditions and effects of drugs and inhibitors.

Évelyne Jacqz-Aigrain, E. Bessa, Yves Médard et al. · British Journal of Clinical Pharmacology · 1994 · 63 citations · Full text

Pharmaceutical Science, Thiopurine Methyltransferase Activity, Pharmacotherapy +19

Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN): Results of a phase II study

José Trigo, Ricardo Hitt, P. Koralewski et al. · Journal of Clinical Oncology · 2004 · 34 citations

Pathology, Phase Ii Study, Cetuximab Monotherapy +16

Pharmacokinetics and distribution of 6-mercaptopurine administered intravenously in children with lymphoblastic leukaemia

Évelyne Jacqz-Aigrain, S. Nafa, Yves Médard et al. · European Journal of Clinical Pharmacology · 1997 · 26 citations

Lymphoblastic Leukaemia, Pediatric Hematology, Pharmacology +3